{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:39:54Z","timestamp":1793381994802,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver failure with hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome with high mortality. The aim of this study was to decipher clinical and laboratory characteristics of hemophagocytic lymphohistiocytosis after definite diagnosis of liver failure and to provide clues for early diagnosis and treatment of HLH in patients with liver failure. Eleven patients diagnosed with liver failure and HLH were retrospectively investigated in this study. All patients presented with jaundice, persistent high-grade fever, pancytopenia, splenomegaly, evidence of hemophagocytes in the bone marrow and laboratory abnormalities indicating HLH. The average interval from the earliest diagnosis of liver failure to a definitive diagnosis of HLH was 17.27 days. Six (54.55%) patients died during follow-up. For patients with liver failure after admission and subsequently definitively diagnosed with HLH, bilirubin and INR were significantly decreased. HLH is definitely diagnosed at an intermediate or late stage when patients have already suffered from liver failure. The initial dose of glucocorticoid (methylprednisolone) was decreased to 1\u20131.5\u2009mg\/kg\/d and gradually reduced thereafter. In conclusion, for patients with liver failure, HLH should be screened as early as possible upon persistent fever, splenomegaly and unexplained pancytopenia. For patients with liver failure and HLH, the dosage of glucocorticoid should be reduced to avoid serious side effects.<\/jats:p>","DOI":"10.1038\/s41598-019-43909-w","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T10:02:51Z","timestamp":1559296971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical characteristics of liver failure with hemophagocytic lymphohistiocytosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Jinling","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"43909_CR1","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for diagnosis and treatment liver failure. Chin J Clin Infect Dis, 5(6), 321\u2013327, http:\/\/dx.chinadoi.cn\/10.3760%2fcma.j.issn.1673-4149.2013.01.001 (2012)."},{"key":"43909_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","volume":"5","author":"R George Melissa","year":"2014","unstructured":"George Melissa, R. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med 5, 69\u201386, https:\/\/doi.org\/10.2147\/JBM.S46255 (2014).","journal-title":"J Blood Med"},{"key":"43909_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0224-y","volume":"10","author":"YY Li Fei.","year":"2015","unstructured":"Li Fei., Y. Y. et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis 10, 20, https:\/\/doi.org\/10.1186\/s13023-015-0224-y (2015).","journal-title":"Orphanet J Rare Dis"},{"key":"43909_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","volume":"59","author":"W Canna Scott","year":"2012","unstructured":"Canna Scott, W. & Behrens Edward, M. Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr. Clin. North Am 59, 329\u2013344, https:\/\/doi.org\/10.1016\/j.pcl.2012.03.002 (2012).","journal-title":"Pediatr. Clin. North Am"},{"key":"43909_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","volume":"39","author":"GN Rosado Flavia","year":"2013","unstructured":"Rosado Flavia, G. N. & Kim Annette, S. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am. J. Clin. Pathol. 39, 713\u2013727, https:\/\/doi.org\/10.1309\/AJCP4ZDKJ4ICOUAT (2013).","journal-title":"Am. J. Clin. Pathol."},{"key":"43909_CR6","doi-asserted-by":"publisher","first-page":"211817","DOI":"10.1136\/bcr-2015-211817","volume":"2015","author":"GR Lu\u00edsa Azevedo","year":"2015","unstructured":"Lu\u00edsa Azevedo, G. R., Joana, S. & Germano, I. The challenging diagnosis of haemophagocytic lymphohistiocytosis in an HIV-infected patient. BMJ Case Rep 2015, 211817, https:\/\/doi.org\/10.1136\/bcr-2015-211817 (2015).","journal-title":"BMJ Case Rep"},{"key":"43909_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MD.0000000000000022","volume":"93","author":"WQ Li Jing","year":"2014","unstructured":"Li Jing, W. Q. et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93, 100\u20135, https:\/\/doi.org\/10.1097\/MD.0000000000000022 (2014).","journal-title":"Medicine (Baltimore)"},{"key":"43909_CR8","doi-asserted-by":"publisher","first-page":"232470961668451","DOI":"10.1177\/2324709616684514","volume":"5","author":"M Mustafa Ali","year":"2017","unstructured":"Mustafa Ali, M., Ruano Mendez, A. L. & Carraway, H. E. Hemophagocytic lymphohistiocytosis in a patient with Hodgkin lymphoma and concurrent EBV, CMV, and Candida Infections. J Investig Med High Impact Case Rep 5, 2324709616684514, https:\/\/doi.org\/10.1177\/2324709616684514 (2017).","journal-title":"J Investig Med High Impact Case Rep"},{"key":"43909_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jceh.2017.01.119","volume":"7","author":"SM Jagtap Nitin.","year":"2017","unstructured":"Jagtap Nitin., S. M. et al. Hemophagocytic Lymphohistiocytosis Masquerading as Acute Liver Failure: A Single Center Experience.[J]. J Clin Exp Hepatol 7, 184\u2013189, https:\/\/doi.org\/10.1016\/j.jceh.2017.01.119 (2017).","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"43909_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"Jan-Inge Henter","year":"2007","unstructured":"Henter Jan-Inge, H. A. et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. [J]. Pediatr Blood Cancer, 2007, 48, 124\u201331, https:\/\/doi.org\/10.1002\/pbc.21039 Delete Article 11, repeat with Article 9 (2007).","journal-title":"Pediatric Blood & Cancer"},{"issue":"47","key":"43909_CR11","doi-asserted-by":"publisher","first-page":"e5431","DOI":"10.1097\/MD.0000000000005431","volume":"95","author":"LY Lin Shide.","year":"2012","unstructured":"Lin Shide., L. Y. et al. Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults: A case report and review of the literature[J]. Medicine, 2016 95(47), e5431, https:\/\/doi.org\/10.1097\/MD.0000000000005431 (2012).","journal-title":"Medicine, 2016"},{"key":"43909_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jbspin.2011.10.015","volume":"79","author":"L Claire","year":"2012","unstructured":"Claire, L. Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment.[J]. Joint Bone Spine 79, 356\u201361, https:\/\/doi.org\/10.1016\/j.jbspin.2011.10.015 (2012).","journal-title":"Joint Bone Spine"},{"key":"43909_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.mayocpiqo.2018.06.006","volume":"2","author":"KB Brito-Zer\u00f3n Pilar","year":"2018","unstructured":"Brito-Zer\u00f3n Pilar, K. B. et al. Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis. [J]. Mayo Clin Proc Innov Qual Outcomes 2, 267\u2013276, https:\/\/doi.org\/10.1016\/j.mayocpiqo.2018.06.006 (2018).","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"43909_CR14","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.clml.2018.06.014","volume":"18","author":"R-RS Apodaca Elia.","year":"2018","unstructured":"Apodaca Elia, R.-R. S. & Juventina, T.-A. E. Demichelis-G\u00f3mez Roberta. Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience.[J]. Clin Lymphoma Myeloma Leuk 18, e373\u2013e380, https:\/\/doi.org\/10.1016\/j.clml.2018.06.014 (2018).","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"43909_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","volume":"114","author":"M Rafa\u0142","year":"2017","unstructured":"Rafa\u0142, M., Gritta, J. & Wieslaw, W.-J. Similar but not the same: Differential diagnosis of HLH and sepsis.[J]. Crit. Rev. Oncol. Hematol 114, 1\u201312, https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.023 (2017).","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"43909_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","volume":"89","author":"A Parikh Sameer","year":"2014","unstructured":"Parikh Sameer, A., Kapoor, P., Letendre, L., Kumar, S. & Wolanskyj, A. P. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.[J]. Mayo Clin. Proc. 89, 484\u201392, https:\/\/doi.org\/10.1016\/j.mayocp.2013.12.012 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"43909_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bjh.13102","volume":"168","author":"FL Arca Marc.","year":"2015","unstructured":"Arca Marc., F. L. et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.[J]. Br. J. Haematol 168, 63\u20138, https:\/\/doi.org\/10.1111\/bjh.13102 (2015).","journal-title":"Br. J. Haematol"},{"key":"43909_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12185-018-2504-5","volume":"108","author":"K Otrock Zaher","year":"2018","unstructured":"Otrock Zaher, K., Grossman Brenda, J. & Eby Charles, S. Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis.[J]. Int. J. Hematol 108, 485\u2013490, https:\/\/doi.org\/10.1007\/s12185-018-2504-5 (2018).","journal-title":"Int. J. Hematol"},{"key":"43909_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1378\/chest.11-0619","volume":"140","author":"A Raschke Robert","year":"2011","unstructured":"Raschke Robert, A. & Garcia-Orr, R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults.[J]. Chest 140, 933\u2013938, https:\/\/doi.org\/10.1378\/chest.11-0619 (2011).","journal-title":"Chest"},{"key":"43909_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11684-013-0292-0","volume":"7","author":"VRG\u2019B Padhi Somanath.","year":"2013","unstructured":"Padhi Somanath., V. R. G.\u2019B., Ramdas, A., Phansalkar, M. D. & Sarangi, R. Hemophagocytic lymphohistiocytosis: critical reappraisal of a potentially under-recognized condition.[J]. Front Med 7, 492\u2013498, https:\/\/doi.org\/10.1007\/s11684-013-0292-0 (2013).","journal-title":"Front Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43909-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43909-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43909-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:00:31Z","timestamp":1671271231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43909-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43909"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43909-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8125"}}